BAM
COLL icon

Ballast Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Ballast Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.74M Buy
113,223
+2,780
+3% +$118K 1.67% 31
2025
Q4 		$5.11M Sell
110,443
-3,872
-3% -$162K 2.42% 15
2025
Q3 		$4M Buy
114,315
+27,109
+31% +$942K 1.83% 26
2025
Q2 		$2.58M Buy
+87,206
New +$2.49M 1.34% 32

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Ballast Asset Management's COLL Position: Q1 2026 in Review

Ballast Asset Management increased its Collegium Pharmaceutical (COLL) stake by 2.5% in Q1 2026, buying an estimated $118K and bringing the position to 113,223 shares worth $3.74M. The position accounts for 1.67% of the portfolio, ranked #31.

Ballast Asset Management first reported a position in COLL in Q2 2025 and has held it in 4 quarters since. The position peaked at $5.11M in Q4 2025. 266 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Ballast Asset Management held 113,223 shares of Collegium Pharmaceutical worth $3.74M as of Q1 2026.
  • Ballast Asset Management bought 2,780 Collegium Pharmaceutical shares in Q1 2026, an estimated $118K.
  • Collegium Pharmaceutical made up 1.67% of Ballast Asset Management's portfolio in Q1 2026, its #31 holding.
  • Ballast Asset Management first reported a position in Collegium Pharmaceutical in Q2 2025 and has held it in 4 quarters since.
  • Ballast Asset Management's Collegium Pharmaceutical position peaked at $5.11M in Q4 2025.
  • 266 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Ballast Asset Management's 13F filing for Q1 2026, filed 7 May 2026.